Meitav Dash Investments LTD Eli Lilly & CO Transaction History

Meitav Dash Investments LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$434.7 - $599.3 $56,511 - $77,909	-130 Reduced 0.6%	21,506 $11.6 Million
Q2 2023 Jul 24, 2023	SELL	$350.74 - $468.98 $124,863 - $166,956	-356 Reduced 1.62%	21,636 $10.1 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $143,511 - $168,546	-462 Reduced 2.06%	21,992 $7.55 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $1.58 Million - $1.84 Million	-4,917 Reduced 17.96%	22,454 $8.21 Million
Q2 2022 Aug 01, 2022	BUY	$278.73 - $327.27 $4.61 Million - $5.41 Million	16,539 Added 152.69%	27,371 $8.87 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $28,162 - $34,999	-120 Reduced 1.1%	10,832 $3.1 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $34,851 - $43,251	155 Added 1.44%	10,952 $3.03 Million
Q1 2021 May 06, 2021	BUY	$164.32 - $212.72 $1.77 Million - $2.3 Million	10,797 New	10,797 $2.02 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.